MedPath

Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion

Phase 1
Conditions
Recurrent Miscarriage
Interventions
Registration Number
NCT03132779
Lead Sponsor
Ahmed Mohamed Bahaa Eldin Ahmed
Brief Summary

Evaluating the effect of intralipid on the natural killer cells

Detailed Description

This study will done on women with recurrent spontaneous abortions having increased NKCELLS activity and evaluate the effect of Intralipid on them after re-estimation of NKcells activity again after one week of Intralipid adminstration

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
34
Inclusion Criteria
  • All women icluded having recurrent spontaneous abortions equal or more than twice.
  • Alittle women having increased NKCELLS activity.
Exclusion Criteria
  • Any other diseases causing miscarriage as autoimmune (lupus erythematosus or antiphospholipid antibodies syndrome )or endocrinopathy (diabetes mellitus, thyroid disorders and hyperprolactinaemia)or thrombophilia (factor v leiden mutation, protein c or s deficiency, prothrombin G20210A mutation, antithrombin III deficiency ) or abnormal karyotyping to one or both of parents or previous history of hormonal contraception or intrauterine device usage at last 3 months or any contraindications for intralipid usage.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
One armedIntralipidOne group of patient will take Intralipid for all
Primary Outcome Measures
NameTimeMethod
Change in NK cells activity after injection of intralipidOne week

NK cells is measured before and after injection of intralipid and is noticed for change in activity

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath